Kansas updates in category: FDA & Prescription Drugs

Baxter International Inc., in conjunction with the FDA, is recalling all remaining lots and doses of heparin sodium vial products, including all multi-dose, single-dose vials and HEP-LOCK heparin flush products. The company recently recalled nine lots of the heparin sodium injection multi-dose vials as a precaution due to more than normal reports of adverse reactions from the product....

Continue article

A new warning could be placed on prescriptions for Prozac and similar antidepressants if drug manufactures follow the recent request of the Food and Drug Administration. The F.D.A. has asked that additional information be added about a rare but potentially fatal lung disorder that can affect babies born to mothers who take the drugs during pregnancy.A warning was also made about the risk of...

Continue article

The heavily debated antibitoic Ketek has been recently linked to liver failure and possibly death. That was the warning given last month as the Food and Drug Administration issued a statement that the drug could, in rare circumstances, cause serious liver damage. Dr. John Jenkins, director of the Food and Drug Administration's Office of New Drugs stated that there is a serious risk of liver...

Continue article

A recent study from the New Zeland Medical Research Institute and published in the Journal of the Royal Society of Medicine has shown that people taking Celebrex double their risk for a heart attack when compared with users of similar drugs. The study looked at six seperate studies involving 12,780 patients in an effort to determine if the increased risk of cardiovascular problems with Vioxx...

Continue article

Vioxx, a non-steroidal anti-inflammatory (NSAID) medication, was prescribed for just five years before its manufacturer, Merck & Co., issued a worldwide voluntary recall. One of the most widely used drugs, Vioxx was prescribed to children and adults to manage symptoms of rheumatoid arthritis, women to ease their menstrual cramps, and a variety of other people to alleviate swelling and acute...

Continue article

A new FDA warning alerts consumers about potential dangers of the Ortho Evra® patch. First approved by the FDA in November 2001, the Ortho Evra® birth control patch is a transdermal patch that is applied to the skin and worn for one week.The patch is replaced every week for 3 weeks, followed by one patch-free week. Currently, Ortho Evra® is the only birth control patch available and its...

Continue article